Evidence map›Paper›PMID 40462406›Full record

ArticleAlcohol, clinical & experimental research2025

Effect of aging on the development and progression of alcohol-associated liver disease.

Ramesh Bellamkonda, Sundararajan Mahalingam, Ojeshvi Ethiraj, Sathish Kumar Perumal, Madan Kumar Arumugam, Daren L Knoell, Kurt W Fisher, Carol A Casey, Kusum K Kharbanda, Karuna Rasineni

Abstract read
In one paragraph

Article in Alcohol, clinical & experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ramesh BellamkondaResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.
Sundararajan MahalingamResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.
Ojeshvi EthirajDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Sathish Kumar PerumalResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.
Madan Kumar ArumugamResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.
Daren L KnoellDepartment of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Kurt W FisherDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Carol A CaseyResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.
Kusum K KharbandaResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.ORCID 0000-0001-7759-8889
Karuna RasineniResearch Service, Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA.ORCID 0000-0002-9581-3957

Funding

The Role of TP-R on Alcohol-Induced Multi-Organ Damage: Liver and HeartP50AA030407 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Carol A. Casey · 2023 to 2026
$7.9M
Role of alcohol-induced ghrelin in modulating organ crosstalk to promote the development of fatty liver diseaseR01AA028504 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI RASINENI, KARUNA · 2021 to 2025
$1.7M
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosisR01AA026723 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KHARBANDA, KUSUM K. · 2018 to 2022
$1.6M
BLRD VA I01 BX004053BLRD VA I01 BX006064BLRD VA IK6 BX004853Department of Veterans Affairs, Veterans Health Administration I01BX004053Department of Veterans Affairs, Veterans Health Administration I01BX006064NIAAA NIH HHS P50 AA030407NIAAA NIH HHS P50AA030407-5131NIAAA NIH HHS R01 AA026723NIAAA NIH HHS R01 AA028504
6 · The paper itself

Abstract

backgroundThere is a robust link between chronic alcohol intake and the development of alcohol-associated liver disease (ALD). Over 90% of excessive alcohol drinkers develop hepatic steatosis that can progress to an advanced liver injury state. However, this progression depends on many extrahepatic factors including age, which is also a predictor of ALD-related mortality. This study aimed to identify selected pathological changes in rats of different ages with chronic ethanol administration for the same duration to gain insights into the effects of aging in the development and progression of ALD.

methodsMale Wistar rats of young (4 months), middle (8-12 months), and older (24 months) age were pair-fed for 6 weeks with Lieber-DeCarli control or ethanol diet. At the end of the experimental period, rats were euthanized and serum and tissues (liver, gut, and adipose) were collected for analyses.

resultsChronic ethanol feeding increased serum hepatic injury markers, circulating nonesterified free fatty acids, and hepatic triglycerides across the different age groups compared to their respective controls, with the higher levels seen in the middle-aged and old ethanol-fed rats compared to young ethanol-fed rats. Further, histopathological evaluation and quantitative analysis of inflammatory and fibrotic markers revealed more progressive liver injury in older ethanol-fed rats compared to young and middle-aged counterparts. We also observed increased intestinal permeability, as indicated by lower ileal expression of tight junction proteins and higher serum endotoxin levels in older ethanol-fed rats. Aging alone adversely affected several of these injury markers in older control-fed rats compared to middle-aged and young control-fed rats.

conclusionOur findings indicate that aging significantly influences the development of liver injury after chronic alcohol intake.

Indexed as

AgingEthanolLiver Diseases, AlcoholicAnimalsDisease ProgressionLiverMaleRatsRats, WistarEthanolagingchronic alcoholgut leakagehepatic fibrosishepatic inflammationliver disease

Identifiers

PMID40462406
PMCPMC12285915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.